Literature DB >> 15835015

Influence of metabolic control on the blood-retinal barrier in streptozocin diabetic rats.

A Kernell1, H Dahlkvist, H Arnqvist, J Ludvigsson.   

Abstract

One hundred and eight male Sprague-Dawley rats weighing 160-225 g were examined with vitreous fluorophotometry (VF). Fifty-five rats were made diabetic with streptozocin (43 with 65 mg/kg and 12 with 90 mg/kg); 53 nondiabetic rats served as controls. Fluorescein (7 mg/kg) was injected IV and VF was performed 60 min later. The diabetic rats had an abnormal blood-retinal barrier (BRB) after 4-7 days duration. The difference between the diabetic and non-diabetic rats was persistent up to 35 days (P < 0.02-0.001). The diabetic rats treated with 90 mg/kg streptozotocin had a more severe diabetes and a higher treated with 65 mg/kg (P < 0.05). The BRB function was normalized in 18 rats treated for 6-7 days with 5-6 IU long-acting insulin (P < 0.02). The results imply that streptozocin-diabetic rats have an abnormal BRB and that this abnormality seems to be related to the diabetic state and to be reversible after insulin treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 15835015     DOI: 10.1007/bf02133669

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  16 in total

Review 1.  The blood-ocular barriers.

Authors:  J Cunha-Vaz
Journal:  Surv Ophthalmol       Date:  1979 Mar-Apr       Impact factor: 6.048

2.  Effects of streptozotocin on carbohydrate and lipid metabolism in the rat.

Authors:  P S Schein; K G Alberti; D H Williamson
Journal:  Endocrinology       Date:  1971-09       Impact factor: 4.736

3.  Streptozotocin diabetes: time course of irreversible B-cell damage; further observations on prevention by nicotinamide.

Authors:  W Stauffacher; I Burr; A Gutzeit; D Beaven; J Veleminsky; A E Renold
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

4.  Ocular fluorophotometry in streptozotocin diabetes mellitus in the rat: effect of pancreatic islet isografts.

Authors:  T Krupin; S R Waltman; D W Scharp; C Oestrich; S D Feldman; B Becker; W F Ballinger; P E Lacy
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-11       Impact factor: 4.799

5.  Early breakdown of the blood-retinal barrier in diabetes.

Authors:  J Cunha-Vaz; J R Faria de Abreu; A J Campos
Journal:  Br J Ophthalmol       Date:  1975-11       Impact factor: 4.638

6.  Kinetic vitreous fluorophotometry in experimental diabetes.

Authors:  C W Jones; J Cunha-Vaz; K O Zweig; M Stein
Journal:  Arch Ophthalmol       Date:  1979-10

7.  A permeability defect of the retinal pigment epithelium. Occurrence in early streptozocin diabetes.

Authors:  W M Kirber; C W Nichols; P A Grimes; A I Winegrad; A M Laties
Journal:  Arch Ophthalmol       Date:  1980-04

8.  Clinicopathologic study of blood-retinal barrier in experimental diabetes mellitus.

Authors:  M O Tso; J G Cunha-Vaz; C Y Shih; C W Jones
Journal:  Arch Ophthalmol       Date:  1980-11

9.  Streptozotocin: its excretion and metabolism in the rat.

Authors:  E H Karunanayake; D J Hearse; G Mellows
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122

10.  Time-course of changes in blood glucose and ketone bodies, plasma lipids and liver fatty acid composition in streptozotocin-diabetic male rats.

Authors:  D L Topping; M E Targ
Journal:  Horm Res       Date:  1975
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.